The stock of Universal Health Services Inc. (NYSE:UHS) increased by $0.16 on Friday to finish at $131.53, up 0.12 percent. The last five days have seen an average of 727,440 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$9.36. The average number of shares traded over the last 20 days was 805,045, while the average volume over the last 50 days totaled 725,788.
UHS stock dropped -14.08% since last month. On 08/10/23, the company’s shares reached a one-month low of $130.82. The stock touched a high of $158.57 on 06/30/23, after rallying from a low of $82.50 in 52 weeks. The price of UHS stock has declined by -6.64% or -$9.36 this year, reaching a new high 9 times. Still, the stock price is down -17.05% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
UHS stock investors should be aware that Universal Health Services Inc. (UHS) stock had its last reported insider trading activity 62 days ago on Jun 13. On Jun 13, Director Nimetz Warren J. sold 800 shares at $140.97 each. This transaction resulted in the insider making $112,776. On May 17, McDonnell Eileen C. sold 1,680 shares at a price of US$134.64. After the transaction, the insider now owns 5,316 shares. Executive Vice President & CFO FILTON STEVE had earlier sold 25,000 shares on May 11 for $139.08 a share. The transaction was completed for $3,477,000.
Valuation Metrics
Universal Health Services Inc. (UHS) has a trailing price-to-earnings (P/E) ratio of 13.66. Beta for the stock is 1.27. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.67, the price-to-book (PB) ratio of 1.51, and the price-to-cash flow ratio of 18.12.
Company paid $0.20 per share in dividends, remained unchanged from $0.20 last year. A $0.10 dividend increase was reported on Thursday July 25 2019.
Financial Health
For the three months ended June 29, Universal Health Services Inc.’s quick ratio was 1.20, while its current ratio was 1.30, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.76, and the total debt to equity ratio is 0.77. Universal Health Services Inc.’s EBITDA margin for the year ended June 29 was 12.26%, whereas its operating margin stood at 7.90% for the same period. Based on annual data, it had gross profit of $11.93 billion and revenue of $13.4 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. UHS’s return on assets (ROA) during the last 12 months has been 5.10%. There was a 7.40% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 11.60%.
Earnings Surprise
According to Universal Health Services Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $3.55 billion, while revenues rose by 6.33% to $3.47 billion. It was predicted that Universal Health Services Inc.’s quarterly earnings would be $2.53, but it ended up being $2.43, beating the consensus by 4.10%. EBITDA was $423.87 million for the quarter. At the end of Universal Health Services Inc.’s most recent quarter ended June 29, its liabilities totaled 7.6 billion, while its total debt was $5.18 billion. Equity owned by shareholders amounts to $69.39 million.
Technical Picture
Here’s a quick look at Universal Health Services Inc.’s (UHS) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 21.77%, suggesting the stock is oversold, with a 21.35% historical volatility rate.
The stochastic %K and %D were 2.37% and 6.48% respectively, while the average true range (ATR) was 3.27. Based on the 14-day stochastic reading of 3.67%, the RSI (14) reading is 26.82%. On the 9-day MACD Oscillator, the stock is at -3.28, and the 14-day reading is at -5.63.
Analyst Ratings
In its most recent analyst report, BofA Securities raised its rating on Universal Health Services Inc. (NYSE: UHS) to a Buy. Prior to this, analysts firm rated the stock as a Neutral. Analysts have assigned Universal Health Services Inc. (UHS) an Overweight rating. UHS is a stock that is recommended for selling by 1 brokerage firm, while 11 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 6 others recommend it as a buy.
What is UHS’s price target for the next 12 months?
The current consensus forecast for the stock is between $142.00 and $183.00, with a median target price of $155.00. In analyzing these forecasts, the average price target given by analysts for Universal Health Services Inc. (UHS) is $159.07.
